A comparative study on efficacy and safety of intravenous iron sucrose and oral iron among anaemic pregnant females


  • Naheed Zia Khan Department of Obstetrics and Gynecology, Hind Institute of Medical Sciences, Safedabad, Barabanki, Uttar Pradesh India
  • Mufazzal Ahmad Senior Consultant Nephrologist, Sahara Hospital, Lucknow, Uttar Pradesh, India
  • Akhilesh Dutt Dwivedi Department of Obstetrics and Gynecology, Hind Institute of Medical Sciences, Safedabad, Barabanki, Uttar Pradesh India
  • Mukesh Shukla Department of Community Medicine, Hind Institute of Medical, Safedabad, Barabanki, Uttar Pradesh, India




Anaemia, Intravenous iron sucrose, Oral Ferrous Sulphate


Background: Iron deficiency anaemia (IDA) is the most common medical problem in pregnancy. Both parenteral and oral iron therapies are modalities used for management of anaemia in pregnant females. The present study aimed to compare the efficacy of oral and intravenous iron therapy in improving iron deficiency anaemia in pregnancy and restoring iron stores, compare the pregnancy outcome in the two groups and evaluate their safety.

Methods: This prospective randomized clinical trial conducted among pregnant women between 14 and 36 weeks with established IDA who were treated with IVIS (Intravenous Iron Sucrose) or OI (ferrous sulphate). All patients were monitored for laboratory response and adverse effects. Independent sample-t test, Chi square test and ANOVA were used for statistical analysis. P <0.05 was considered significant.

Results: From first follow up till the end of the study the mean hemoglobin level of IV Group was found to be significantly higher as compared to that of oral Group. The MCV (mean corpuscular volume) values increased to a significant level in the intravenous group as compare to oral. After therapy increase transferrin saturation in the intravenous group were significantly higher at all-time interval than the oral group. The mean neonatal hemoglobin at birth was significantly higher in IV group 16.88±1.96 gm/dl than oral group 16.88±1.96 (p= p<0.0001).

Conclusions: Intravenous iron sucrose is comparatively more efficient in improving haemoglobin than oral iron and has better pregnancy outcomes.


Anaemia is on the rise in India says NFHS report. [Online]. 2008 Jul 17 [cited 2010 Oct 27]; Available from: URL:http://www.expressindia.com/latest-news/Anaemia-is-on-the-rise-in-India-says-NFHS-report/336854

World Health Organization, Centers for Disease Control and Prevention. de Benoist B, McLean E, Egli I, Cogswell M, eds. Worldwide prevalence of anaemia 1993–2005. Geneva, World Health Organization, 2008.

Letsky EA. The hematological system. In clinical physiology in obstetric (2nd ed.) Blackwell Science, Oxford publications;1991:39-82.

Premonanda B, Som, Superna, Chakrabaety, Manoranjan P, et al. Prevalence of anemia and its determinants among non pregnant and pregnant women in India. Asia Pacific J Health. 2008;20:347-59.

Looker AC, Dallman PR. Prevalence of Iron deficiency United States. JAMA. 1997;277(97):973-6.

Scott DE. Anemia during pregnancy. Obstet Gynecol Ann. 1972;1:219.

Perry GS, Yip R, Zyrkowski C. Nutritional risk factors among low-income pregnant US women: the Centers for Disease Control and Prevention (CDC) Pregnancy Nutrition Surveillance System, 1979 through 1993. Semin Perinatol. 1995;19(3):211-21.

Schooll TO, Hediger ML, Fisher RL, Shearer JW. Anemia versus iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr. 1992;55:985-8.

Mukherji J, Ganguly RP, Saha SK, Ray SCH. Postpartum care: a neglected tragedy. J Obstet Gynecol India. 2002;52(4):40-3.

Indian Council of Medical Research Supplementation trial in pregnant women with 60mg, 120mg and 180mg Iron with 500 of folic acid, New Delhi, ICMR. 1992:641.

Schultink W. Iron supplementation programmes: Compliance of target groups and frequency of tablet intake. Food Nutr Bull. 1996;17:22-6.

WHO fact sheet no. 276/Feb. 2004. WHO. The World Health Report: Redwing ristis, promoting healthy life, Geneva, 2002.

Al Momen AK, Al Meshari A, al Nuaim L, Saddique A, Abotalib Z, Khashog T et al. Intervention iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eurp J Obstet Gynecol. Reprod Biol. 1956;69:121-4.

Al RA, Unlubilgin E, Kandemir O, Yalvaes Cakir L, Haberal A. Intravenous versus oral Iron for treatment of Anemia in pregnancy, Randomized trial. Am J Obstet Gynecol. 2005;106(6):1335-40.

Singh K, Fong YF, Kuperan P. A comparison between intravenous iron Polymaltose complex and oral ferrous fumarate deficiency in the treatment of iron deficiency anemia in pregnancy. Eur J Haematol. 1998;60:119-124.

Millman N, Bergholt, Byg KE, Eri K. Iron standard Iron balance during pregnancy. A critical re appraisal of Iron supplements. Acta Obst Conti Acta Obstet Gynecol Scand. 1969;78:749-57.

Bhandal N, Russell R. Intravenous verses oral iron therapy for postpartum anemia British J Obstet Gynecol. 2006:1248-52.

Dede A, Uygur D, Yilmaz B. Intravenous iron sucrose complex verses ferrous sulphate for postpartum iron deficiency anemia. Int J Obstet Gynecol. 2005;90:238-9.

Bayoumeu F, Subiran Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC et al. Iron therapy in iron deficiency anemia in pregnancy: intravenous versus oral route. Am J Obstet Gynecol. 2002;186(3):518-522.

Bencaiova G, von Mandach U, Zimmermann R. Iron prophylaxis in pregnancy: intravenous route versus oral route. Eur J Obstet Gynecol Reprod Biol. 2009;144(2):135-9.

Oski FA. Iron deficiency in infancy and childhood. N Engl J Med. 1993;329:190-3.

Idjradinata P, Pollitt, E. Reversal of developmental delays in iron-deficient anaemic infants treated with iron. Lancet. 1993;341:1-4.






Original Research Articles